Investment
Features
FeesSafety
Academy
More
Pluang+

uniQure reports 4-year data showing slowed Huntington's disease progression with gene therapy AMT-130

Analyst Insights
30 Sep 2026
Seeking Alpha
View Source
Bullish
uniQure reports 4-year data showing slowed Huntington's disease progression with gene therapy AMT-130

uniQure released four-year data from its phase 1/2 trial of AMT-130, a gene therapy for Huntington's Disease. The data showed a 44% slowing in disease progression measured by cUHDRS at year 4, though this result was not statistically significant, possibly due to missing data and survivor bias. However, the total functional capacity (TFC) measure, the primary endpoint for the ongoing phase 3 trial, showed over 60% slowing with statistically significant results. These findings support AMT-130's potential to slow Huntington's Disease progression, with further confirmation expected from the phase 3 trial.

The story covers uniQure's updated 4-year trial data for its Huntington's Disease gene therapy. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 01, 2026 00:03 WIB: out of 100 priced US health stocks, 52 rose and 48 fell. Notable movers include HIMS at USD 30.59 (+6.59%), TWST at USD 196.47 (+5.56%), and SMMT at USD 17.24 (+5.44%).

More News

Elauwit investors may claim losses after company revises financials, causing stock to drop 6.8%.

Elauwit investors may claim losses after company revises financials, causing stock to drop 6.8%.

Elauwit Connection, Inc. announced a restatement of its financial results due to errors in revenue recognition related to a network construction project. This disclosure led to a 6.8% drop in its stock price. The Rosen Law Firm is investigating poten...

Market News
Bearish
4 hours ago
TETRA Technologies to report Q3 2026 results on Nov 2, with a conference call on Nov 3.

TETRA Technologies to report Q3 2026 results on Nov 2, with a conference call on Nov 3.

TETRA Technologies, an energy services company, will announce its third quarter 2026 financial results after market close on November 2, 2026. The company will hold a conference call on November 3 to discuss these results and provide an outlook. TETR...

Company Fundamentals
Neutral
4 hours ago
XRP may be set for a major rally, says trader who predicted 2024 breakout, but details remain private.

XRP may be set for a major rally, says trader who predicted 2024 breakout, but details remain private.

A trader known as Crypto Michael, who accurately predicted XRP's breakout above $3 in 2024, is now signaling another potential parabolic rally for the cryptocurrency. He has teased a bullish setup but has kept the specifics, including price targets a...

Market News
Bullish
4 hours ago
JLL Income Property Trust buys $90M Worcester Distribution Center, boosting its industrial real estate portfolio.

JLL Income Property Trust buys $90M Worcester Distribution Center, boosting its industrial real estate portfolio.

JLL Income Property Trust acquired the Worcester Distribution Center, a 396,000 sq ft Class A industrial building in the Boston area, for about $90 million. The property, built in 2022 and fully leased to a single tenant, features advanced storage ca...

Company Fundamentals
Bullish
4 hours ago
Sui blocks 3,023 crypto phishing threats via $10M security push with ChainPatrol

Sui blocks 3,023 crypto phishing threats via $10M security push with ChainPatrol

Sui has successfully removed 3,023 impersonation and phishing threats across various online platforms through its partnership with security firm ChainPatrol. This effort is part of Sui's $10 million Ecosystem Security Expansion Initiative, which prot...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App